US Patent Issued to AurimMed Pharma on Dec. 2 for "Compounds advantageous in the treatment of central nervous system diseases and disorders" (Utah Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,218, issued on Dec. 2, was assigned to AurimMed Pharma Inc. (Salt Lake City).

"Compounds advantageous in the treatment of central nervous system diseases and disorders" was invented by Amir Pesyan (Park City, Utah) and Manuel F. Balandrin (Sandy, Utah).

According to the abstract* released by the U.S. Patent & Trademark Office: "A series of novel amides showing broad pharmaceutical activity. Compounds described herein are effective as anticonvulsants, chemical countermeasures, and analgesics. Such compounds also show, neuroprotective/neuroreparative effects and activity against spinal muscular atrophy. Such pharmaceutically active compounds show utility in the treatment of central ...